Alliance Pharma Share Price | |
---|---|
Price | 36.35 |
Bid | 36.05 |
Ask | 38.45 |
Change | -0.45 (-1.22%) |
Volume | 921,527 |
Open | 36.95 |
High | 37.10 |
Low | 36.05 |
Prev. Close | 36.80 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 540.40m |
Market Capitalisation | £196.43m |
Market Size | 20,000 |
52 Week High | 72.60 |
52 Week High Date | 17-May-2023 |
52 Week Low | 33.70 |
52 Week Low Date | 10-Nov-2023 |
# Trades | 152 |
---|---|
Vol. Sold | 514,847 |
Sold Value | £187.87k |
Vol. Bought | 258,123 |
Bought Value | £94.22k |
PE Ratio | 213.82353 |
Earnings | 0.17 |
Dividend | 1.691 |
Yield | 4.652% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
18-Mar-24 | 17:47:24 | 36.35 | 1,487 | Unknown* | 36.05 | 38.45 | 540.52 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:44:42 | 36.457 | 10,694 | Unknown* | 36.05 | 38.45 | 3,899 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:05:21 | 36.35 | 957 | Unknown* | 36.05 | 38.45 | 347.87 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:05:18 | 36.35 | 808 | Unknown* | 36.05 | 38.45 | 293.71 | O Ordinary Was reported as OTC |
18-Mar-24 | 17:00:48 | 36.753 | 500 | Unknown* | 36.05 | 38.45 | 183.77 | O Ordinary Was reported as OTC |
18-Mar-24 | 16:35:16 | 36.35 | 20,233 | Sell* | 36.05 | 38.45 | 7,355 | UT Uncrossing Trade |
18-Mar-24 | 16:29:56 | 36.05 | 54 | Sell* | 36.05 | 37.45 | 19.47 | A Automatic Execution |
18-Mar-24 | 16:29:56 | 36.05 | 58 | Sell* | 36.05 | 37.45 | 20.91 | A Automatic Execution |
18-Mar-24 | 16:29:56 | 36.05 | 31 | Sell* | 36.05 | 37.45 | 11.18 | A Automatic Execution |
18-Mar-24 | 16:27:58 | 36.65 | 312 | Sell* | 36.65 | 36.70 | 114.35 | A Automatic Execution |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Oct-23 | 13-Oct-23 | Exercise of Option | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 1.00 | GBX | 55,592 | 248,503 |
16-Oct-23 | 13-Oct-23 | Sell | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 39.02 | GBX | 74,343 | 696,686 |
16-Oct-23 | 13-Oct-23 | Sell | Andrew Franklin held the position of CFO at the time of this trade.Andrew Franklin | 39.02 | GBX | 42,053 | 248,503 |
16-Oct-23 | 13-Oct-23 | Exercise of Option | Peter Butterfield held the position of CEO at the time of this trade.Peter Butterfield | 1.00 | GBX | 98,342 | 696,686 |
20-Jul-23 | 20-Jul-23 | Buy | Jo Le Couilliard held the position of Chairman at the time of this trade.Jo Le Couilliard | 48.80 | GBX | 40,957 | 40,957 |
We have a proven, consistent track record that enables us to invest for both organic growth and acquisitions